trending Market Intelligence /marketintelligence/en/news-insights/trending/mqGVXKP-nKi8_aByelO3uA2 content esgSubNav
In This List

Cyclo Therapeutics completes name change

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Cyclo Therapeutics completes name change

Cyclo Therapeutics Inc. completed its name change after receiving necessary approvals from its shareholders and relevant regulators.

The Alachua, Fla.-based biotechnology, which develops cyclodextrin-based drugs, previously operated as CTD Holdings Inc.

The company's shares will continue trading on the OTCQB exchange under the ticker symbol CTDH, Cyclo Therapeutics noted in its Oct. 4 news release.